Büscheck, F., Zub, M., Heumann, A., Hube-Magg, C., Simon, R., Lang, D. S., Höflmayer, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Sauter, G., Huland, H., Graefen, M., Haese, A., Heinzer, H., Schlomm, T., Clauditz, T. S., Burandt, E., Wilczak, W., Steurer, S., & Minner, S. (2019). the independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer. Tumor biology, 41(7), . http://access.bl.uk/ark:/81055/vdc_100086581832.0x000003